Dextromethorphan Added on for the Patients With ADHD
NCT01787136 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-04-29
Summary
Dextromethorphan added on methylphenidate for the patients with attention deficit hyperactivity disorder
Conditions
- Attention Deficit Hyperactivity Disorder
Interventions
- DRUG
-
Dextromethorphan
added on therapy
Sponsors & Collaborators
-
Tri-Service General Hospital
lead OTHER
Eligibility
- Min Age
- 6 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
NCT00181571 ·Status: COMPLETED ·Phase: PHASE4
-
Enhancing ADHD Driving Performance With Stimulant Medication
NCT00572026 ·Status: UNKNOWN ·Phase: NA
-
Stimulant Effects on Brain Activity
NCT02453698 ·Status: COMPLETED ·Phase: PHASE1
-
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
NCT02951754 ·Status: RECRUITING ·Phase: PHASE4
-
Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT04027361 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
NCT02734693 ·Status: COMPLETED ·Phase: PHASE3
-
Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD
NCT04577417 ·Status: COMPLETED
-
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
NCT02247986 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.
NCT00246220 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
NCT00178503 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
NCT00824317 ·Status: COMPLETED ·Phase: NA
-
Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities
NCT05301361 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.
NCT01825577 ·Status: TERMINATED ·Phase: PHASE4
-
Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
NCT01863459 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
NCT05286762 ·Status: COMPLETED ·Phase: PHASE3
-
Dasotraline Adult ADHD Study
NCT02276209 ·Status: COMPLETED ·Phase: PHASE3
-
Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
NCT01130467 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
NCT03231800 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients With Alcoholism and Attention Deficit Disorder
NCT00261872 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
NCT02096952 ·Status: COMPLETED ·Phase: PHASE4
-
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02083783 ·Status: COMPLETED ·Phase: PHASE3
-
Adult Attention Deficit Hyperactivity Disorder
NCT01692782 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
NCT00586157 ·Status: COMPLETED ·Phase: PHASE4
-
Neuromodulation of Executive Function in the ADHD Brain
NCT04175028 ·Status: COMPLETED ·Phase: NA
-
Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
NCT00536419 ·Status: UNKNOWN ·Phase: PHASE4